DNMR - Danimer Scientific, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
53,218
53,218
58,749
47,333
32,344
Cost of revenue
63,632
63,632
57,865
35,876
21,237
Gross profit
-10,414
-10,414
884
11,457
11,107
Operating expenses
Research development
31,939
31,939
20,270
7,851
5,482
Selling general and administrative
81,589
81,589
80,004
19,343
16,027
Total operating expenses
113,528
113,528
100,274
27,194
21,509
Operating income or loss
-123,942
-123,942
-99,390
-15,737
-10,402
Interest expense
-
-
763
2,427
3,475
Total other income/expenses net
-54,903
-54,903
26,813
5,244
-1,892
Income before tax
-180,568
-180,568
-73,340
-12,573
-15,429
Income tax expense
-810
-810
-13,233
0
4,085
Income from continuing operations
-179,758
-179,758
-60,107
-12,573
-19,514
Net income
-179,758
-179,758
-60,107
-12,573
-19,514
Net income available to common shareholders
-179,758
-179,758
-60,107
-12,573
-19,514
Basic EPS
-
-1.78
-0.65
-0.30
-0.23
Diluted EPS
-
-1.78
-0.65
-0.30
-0.23
Basic average shares
-
101,095
93,078
29,571
85,725
Diluted average shares
-
101,095
93,078
29,571
85,725
EBITDA
-
-103,856
-61,943
-5,023
-6,333